Treatment of sleep apnea in congestive heart failure with a dental device: The effect on brain natriuretic peptide and quality of life

Sleep and Breathing

Volumn 10, Issue 2, 2006, Pages 90-97

  Eskafi, Mahmoud ^a   Cline, Charles ^b   Nilner, Maria ^a   Israelsson, Bo ^c  

^a MALMÖ UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brain natriuretic peptide; Congestive heart failure; Mandibular advancement device; Quality of life; Sleep apnea

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM ANTAGONIST; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; DAYTIME SOMNOLENCE; DENTAL DEVICE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMMUNOASSAY; MALE; MANDIBLE PROSTHESIS; NARCOLEPSY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; QUESTIONNAIRE; RANK SUM TEST; SLEEP APNEA SYNDROME; TREATMENT OUTCOME;

AGED; BRAIN; HEART FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MANDIBULAR ADVANCEMENT; NATRIURETIC PEPTIDES; POLYSOMNOGRAPHY; PROSTHESIS DESIGN; QUALITY OF LIFE; SLEEP APNEA, OBSTRUCTIVE;

EID: 33746871128     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-006-0053-2     Document Type: Article

References (39)

1. Maisel AS, Krishnaswamy P, Nowak RM et al (2002) For the breathing not properly multinational study investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161-167
2. Onuoha GN, Nicholls DP, Patterson A, Beringer T (1998) Neuropeptide secretion in exercise. Neuropeptides 32:319-325
3. Shapiro BP, Chen HH, Burnett JC, Redfield MM (2003) Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure. Mayo Clin Proc 78:481-486
4. Doggrell SA (2001) Brain natriuretic peptide: Disease marker or more in cardiovascular medicine? Drugs Today (Barc) 37:463-476
5. Berger R, Huelsman M, Strecker K et al (2002) B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105:2392-2397
6. Latini R, Masson S, Anand I et al (2004) For the Val-HeFT investigators. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J 25:292-299
7. Javaheri S, Parker TJ, Liming JD et al (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences and presentations. Circulation 97:2154-2159
8. Naughton MT, Bradley TD (1998) Sleep apnea in congestive heart failure. Clin Chest Med 19:99-113
9. Peker Y, Hedner J, Kraiczi H, Loth S (2000) Respiratory disturbance index: An independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162:81-86
10. Milleron O, Pilliere R, Foucher A et al (2004) Benefits of obstructive sleep apnoea treatment in coronary artery disease: A long-term follow-up study. Eur Heart J 25:728-734
11. Kita H, Ohi M, Chin K et al (1998) The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure. J Sleep Res 7:199-207
12. Yan AT, Bradley TD, Liu PP (2001) The role of continuous positive airway pressure in the treatment of congestive heart failure. Chest 120:1675-1685
13. Bradley TD, Floras JS (1996) Pathophysiologic and therapeutic implications of sleep apnea in congestive heart failure. J Card Fail 2:223-240
14. Silverberg DS, Iaina A, Oksenberg A (2002) Treating obstructive sleep apnea improves essential hypertension and quality of life. Am Fam Physician 65:229-236
15. Cline CM, Willenheimer RB, Erhardt LR, Wiklund I, Israelsson BY (1999) Health-related quality of life in elderly patients with heart failure. Scand Cardiovasc J 33:278-285
16. Fransson AM, Isacsson G, Leissner LC, Nasman AB, Alton MK (2001) Treatment of snoring and obstructive sleep apnea with a mandibular protruding device: An open-label study. Sleep Breath 5:23-33
17. Marklund M, Sahlin C, Stenlund H, Persson M, Franklin KA (2001) Mandibular advancement device in patients with obstructive sleep apnea: long-term effects on apnea and sleep. Chest 120:162-169
18. Yoshida K (2000) Effects of a mandibular advancement device for the treatment of sleep apnea syndrome and snoring on respiratory function and sleep quality. Cranio 18:98-105
19. Wilhelmsson B, Tegelberg A, Walker-Engstrom ML et al (1999) A prospective randomized study of a dental appliance compared with uvulopalatopharyngoplasty in treatment of obstructive sleep apnea. Acta Otolaryngol 119:503-509
20. O'Sullivan RA, Hillman DR, Mateljan R, Pantin C, Finucane KE (1995) Mandibular advancement splint: An appliance to treat snoring and obstructive sleep apnea. Am J Respir Crit Care Med 151:194-198
21. Eveloff SE, Rosenberg CL, Carlisle CC, Millman RP (1994) Efficacy of a Herbst mandibular advancement device in obstructive sleep apnea. Am J Respir Crit Care Med 149:905-909
22. Nakazawa Y, Sakamoto T, Yasutake R et al (1992) Treatment of sleep apnea with prosthetic mandibular advancement (PMA). Sleep 15:499-504
23. Eskafi M, Cline C, Israelsson B, Nilner M (2004) A mandibular advancement device reduces sleep disordered breathing in patients with congestive heart failure. Swed Dent J 28:155-163
24. Willenheimer R, Cline C, Erhardt L, Israelsson B (1997) Left ventricular atrioventricular plane displacement: An echocardiographic technique for rapid assessment of prognosis in heart failure. Heart 78:230-236
25. Remme WJ, Swedberg K (2001) Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22:1527-1560
26. Folland ED, Parisi AF, Moynihan PF, Jones DR, Feldman C, Tow DE (1979) Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. Circulation 60:760-766
27. Rector TS, Kubo SH, Cohn JN (1987) Patients' self-assessment of their congestive heart failure. Part 2: Content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Fail 1:198-209
28. Williams SG, Ng LL, O'Brien RJ, Taylor S, Li YF, Tan LB (2004) Comparison of plasma N-brain natriuretic peptide, peak oxygen consumption, and left ventricular ejection fraction for severity of chronic heart failure. Am J Cardiol 93:1560-1561
29. Troughton RW, Prior DL, Pereira JJ et al (2004) Plasma B-type natriuretic peptide levels in systolic heart failure: Importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 43:416-422
30. Cheng V, Kazanagra R, Garcia A et al (2001) A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study. J Am Coll Cardiol 37:386-391
31. Bettencourt P, Ferreira S, Azevedo A, Ferreira A (2002) Preliminary data on the usefulness of B-type natriuretic peptide levels in predicting outcomes after hospital discharge in patients with heart failure. Am J Med 113:215-219
32. Tkacova R, Liu PP, Naughton MT, Bradley TD (1997) Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure. J Am Coll Cardiol 30:739-745
33. Chen HH, Burnett JC (1999) The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Proc Assoc Am Physicians 111:406-416
34. Eskafi M, Cline C, Petersson A, Israelsson B, Nilner M (2004) The effect of mandibular advancement device on pharyngeal airway dimension in patients with congestive heart failure treated for sleep apnoea. Swed Dent J 28:1-9
35. Farrow SJ (1991) Successful treatment of central sleep apnea with an oral prosthesis. Chest 100:1461-1462
36. Issa F, Sullivan C (1986) Reversals of central sleep apnea using nasal CPAP. Chest 90:165-171
37. Hillarp B, Nylander G, Rosén I, Wickström O (1996) Videoradiography of patients with habitual snoring and/or sleep apnea. Acta Radiol 37:307-314
38. De Backer WA (1995) Central sleep apnoea, pathogenesis and treatment: An overview and perspective. Eur Respir J 8:1372-1383
39. Eskafi M, Ekberg E, Cline C, Israelsson B, Nilner M (2004) Use of a mandibular advancement device in patients with congestive heart failure and sleep apnoea. Gerodontology 21:100-107